St. Louis, MO, United States of America

Ronald E Worthington


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Ronald E. Worthington

Introduction

Ronald E. Worthington is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of biotechnology, particularly through his work on phosphoethanolamine N-methyltransferase-like sequences. With a total of 3 patents, his innovations have the potential to impact various applications in science and medicine.

Latest Patents

Among his latest patents, Worthington has developed nucleic acid molecules from nematodes that encode phosphoethanolamine N-methyltransferase polypeptides. These patents describe PEAMT-like polypeptide sequences, as well as vectors, host cells, and recombinant methods for the production of PEAMT-like nucleotides and polypeptides. Additionally, he has outlined screening methods for identifying inhibitors and/or activators, along with methods for antibody production.

Career Highlights

Ronald E. Worthington is currently associated with Divergence, Inc., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding of nematode biology and its applications.

Collaborations

Some of his notable coworkers include Deryck Jeremy Williams and Merry B. McLaird. Their collaborative efforts have further enhanced the research and development initiatives at Divergence, Inc.

Conclusion

Ronald E. Worthington's contributions to biotechnology through his patents and collaborative work exemplify the innovative spirit of modern science. His research continues to pave the way for advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…